NCT06181045View on ClinicalTrials.gov

A Study of LY3410738 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

August 4, 2021

Study Completion Date

August 4, 2021

Conditions

Healthy

Interventions

DRUG

LY3410738

Administered orally.

DRUG

Placebo

Administered orally.

Trial Locations (2)

32117

Covance Clinical Research Unit, Daytona Beach

53704

Covance Clinical Research Unit, Madison

Sponsors

Collaborators (1)

Loxo Oncology, Inc.

All Listed Sponsors

collaborator

Loxo Oncology, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT06181045 - A Study of LY3410738 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter